Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]

INTRODUCTION: The aim of this study was to assess the efficacy of two dosing schedules of recombinant human erythropoietin (rHuEPO) in increasing haematocrit (Hct) and haemoglobin (Hb) and reducing exposure to allogeneic red blood cell (RBC) transfusion in critically ill patients. METHOD: This was a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Georgopoulos, Dimitris, Matamis, Dimitris, Routsi, Christina, Michalopoulos, Argiris, Maggina, Nina, Dimopoulos, George, Zakynthinos, Epaminondas, Nakos, George, Thomopoulos, George, Mandragos, Kostas, Maniatis, Alice
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2005
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1297615/
https://ncbi.nlm.nih.gov/pubmed/16277712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc3786
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars